Sera Prognostics (SERA) Gross Margin Growth (1y) (2025 - 2026)

Sera Prognostics (SERA) Gross Margin Growth (1y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (1y) (Qtr)
1 Abbott Laboratories 183.06 Bn 175.76 Bn 6.27 Bn -67.00
2 Stryker 128.66 Bn 125.78 Bn 3.81 Bn -54.00
3 Medtronic 108.82 Bn 99.60 Bn 6.41 Bn 60.00
4 Boston Scientific 68.43 Bn 66.98 Bn 3.61 Bn 62.00
5 Edwards Lifesciences 48.29 Bn 44.61 Bn 1.29 Bn -65.00
6 GE HealthCare Technologies 28.37 Bn 26.08 Bn 1.98 Bn -359.00
7 Dexcom 28.29 Bn 27.18 Bn 750.30 Mn 610.00
8 Smith & Nephew 26.89 Bn 26.31 Bn - -
9 Koninklijke Philips 25.43 Bn 22.31 Bn 2.07 Bn 9.00
10 Sera Prognostics 102.28 Mn 102.28 Mn -28,000.00 -19,474.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -19,474.00
Dec 31, 2025 -28,667.00
Sep 30, 2025 -21,142.00
Jun 30, 2025 -15,784.00